Journal article icon

Journal article

Second-line therapy in diffuse large B-cell lymphoma (DLBCL): treatment patterns and outcomes in older patients receiving outpatient chemotherapy.

Abstract:

Using SEER-Medicare linked data we identified elderly patients diagnosed with diffuse large B-cell lymphoma (DLBCL) between January 2000 and December 2007 who received second-line outpatient chemotherapy for relapsed or refractory disease. Second-line regimens were classified into three mutually exclusive groups: aggressive, conventional, and palliative. Of the 632 (426 relapsed, 206 refractory) patients in the cohort, 27.8% received aggressive second-line therapy, 39.1% received conventional...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Authors


More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
Primary Care; Primary Care Health Sciences
Role:
Author
Expand authors...
Astra Zeneca More from this funder
Publisher:
Taylor and Francis Publisher's website
Journal:
Leukemia & Lymphoma Journal website
Volume:
58
Issue:
5
Pages:
1094-1104
Publication date:
2016-09-05
Acceptance date:
2016-08-21
DOI:
EISSN:
1029-2403
ISSN:
1042-8194
Pubs id:
pubs:646468
URN:
uri:aefa8d24-7f54-4569-8370-f0ef41af4df9
UUID:
uuid:aefa8d24-7f54-4569-8370-f0ef41af4df9
Local pid:
pubs:646468

Terms of use


Metrics


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP